Search results
What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? - Aethlon Medical...
Benzinga· 6 days ago“The positive data from this in vitro binding study of the Hemopurifier is an important step...
Stocks of local interest
Clinton Herald, Iowa via Yahoo Finance· 6 days agoMay 10—Closing prices Friday: Adv Auto Parts 75.04 Abbott Labs 104.74 ADM 62.98 Ameriprise 433.55 AutoZone, Inc. 2,976.06 Boeing 178.51 Bank of America 38.45 BP PLC ADR 37.84 ConAgra Foods 31.13 ...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks· 3 days agoMerck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.
Off the news: New dengue vaccine eyed as cases grow | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 3 days agoWith a state of emergency in Puerto Rico, where mosquito-spread dengue fever is endemic, and two cases of travel-related dengue fever reported in Hawaii last month, a push is growing for U.S ...
Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination...
Benzinga· 3 days agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that
NJ Innovation Institute signs on to SciTech Scity
NJBIZ· 6 days agoThe highly anticipated SciTech Scity project at Liberty Science Center in Jersey City marked another major development May 9, as the New Jersey...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks· 18 hours agoPharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH Quick QuoteXPH - Free Report) is a passively managed exchange traded fund launched on 06/19/2006. While an excellent ...
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting
Digital Journal· 3 days agoASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation of their prior publication policy based solely on their review of ...
Robert Bruce's Strategic Moves in Q1 2024: Spotlight on Xcel Ene
Guru Focus· 3 days agoInsights into the Investment Shifts of Bruce & Co Robert Bruce (Trades, Portfolio), the seasoned investor behind Bruce & Co, has made notable adjustments to hi